KLOTHO-MRNA

Patent europeic · EP4669333 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4669333
Numer da la dumonda
EP24725642
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
22-03-2024
Publitgà
31-12-2025
Concedì
17-06-2026
La protecziun finescha il pli tard
21-03-2044
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
A61K 38/00 (2006.01)
A61K 48/00 (2006.01)
A61K 38/17 (2006.01)
A61Q 19/08 (2006.01)
A61P 43/00 (2006.01)
C12N 9/14 (2006.01)
C12N 9/24 (2006.01)
Prioritad
EP 23163488 22.03.2023
Dumonda PCT
PCT/US2024/021148 22.03.2024
Publicaziun PCT
WO2024/197254 26.09.2024
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 19-06-2026

    Represchentant inscrit

    Representative
    PRINS Intellectual Property AG, Mellingerstrasse 12, 5443 Niederrohrdorf

    Published in Swissreg on 19.06.2026

  2. 17-06-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 17.06.2026

Partidas

Possessur

ADvantage Therapeutics, Inc.

195 NW 40th Street, Miami, FL 33127, US

Represchentant

PRINS Intellectual Property AG

Mellingerstrasse 12, 5443 Niederrohrdorf

Inventur

HOFFMANN, Thomas

1220 Wien, AT

FERNANDEZ SANTANA III, Agustin

Coral Gables, FL 33134, US

SCHMIDT, Walter

1020 Wien, AT

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.